Ibrahim et al.
JOCArticle
147.1, 148.4, 167.3. 15N NMR (CDCl3): δ 139.6. HRMS =
616.2565 (C38H36N2O6 requires 616.2567).
(d, 2H, J 10.8), 4.70 (d, 2H, J 9.6), 4.74 (d, 2H, J 9.6), 5.05 (d, 2H,
J 4.6), 5.41 (d, 2H, J 4.6), 5.86 (dd, 2H, J 7.8, 1.6), 6.22 (t, 2H,
J 4.7), 6.58 (td, 2H, J 7.6, 1.3), 6.90 (dd, 2H, J 8.0, 1.3), 6.98 (td,
2H, J 7.8, 1.6), 7.41 (m, 10H). 13C NMR (CDCl3): δ 36.8, 61.3,
62.2, 85.6, 112.6, 120.7, 122.8, 124.9, 128.2, 128.3, 128.5, 128.7,
131.2, 146.2, 150.0, 167.7.
Compound 11a. Yield 0.33 g (45%); colorless crystals, mp
149 °C, Rf = 0.23 (pet. Ether/EtOAc 2:1). MS: m/z = 616 (Mþ,
5%). IR: 3065, 3034, 2984, 2922, 2860, 1759, 1500, 1455, 1407,
1357, 1258, 1212, 744, 702. 1H NMR(CDCl3): δ 3.10 (m 2H), 3.71
(m, 2H), 4.30 (dt, 4H, J 5.1, 1.6), 4.77 (d, 2H, J 4.6), 5.15 (ddd, 2H,
J 10.6, 2.8, 1.6), 5.21 (ddd, 2H, J 17.2, 3.2, 1.6), 5.26 (d, 2H, J 4.6),
5.87 (m, 2H), 6.66 (dd, 2H, J 8.5, 1.6), 6.75 (m, 4H), 6.84 (dt, 2H,
J 1.5, 7.2), 7.34 (m, 10H). 13C NMR (CDCl3): δ 37.9, 62.1, 70.0,
83.4, 115.4, 117.1, 117.2, 121.3, 123.0, 128.5, 128.6, 128.9, 133.0,
133.3, 147.2, 148.5, 166.4. 15N NMR (CDCl3): δ 139.3. HRMS =
616.2567 (C38H36N2O6 requires 616.2567).
General Procedures of the RCM. (Condition A) To a solution
of each of the appropriate β-lactams 6-15 (0.03 mmol) in DCM
(10 mL) was added Grubb’s catalyst II (1.2 mg, 5 mol %). The
reaction mixture was heated under reflux for 1 h, the solvent was
removed in vacuo, and the product was purified by column
chromatography with eluent DCM/pet. ether (60-80)/EtOAc
to give the corresponding E isomers 16-25. (Condition B) To a
solution of each of the appropriate β-lactams 6-15 (0.03 mmol)
in DCM (10 mL) was added Grubb’s catalyst I (1.2 mg,
5 mol %). The reaction mixture was heated under reflux for
1 h, the solvent was removed in vacuo, and the product was
purified by column chromatography with eluent DCM/pet.
ether (60-80)/EtOAc to give mixture of the coresponding
E and Z isomer. 1H NMR and 13C NMR data of the Z isomer
were extracted from the mixed spectra by comparison with the
pure E isomer.
Compound 21a-E. Yield 0.58 g (98%) (Condition A), 0.52 g
(88%) (Condition B), colorless oil, Rf = 0.46 (DCM/pet. ether/
EtOAc 1:1:1). MS: m/z = 588 (Mþ, 25%). HRMS = 588.2254
(C36H32N2O6 requires 588.2254). IR: 3064, 2957, 2928, 2860,
1
1762, 1729, 1497, 1460, 1381, 1272, 1124, 1072, 745, 702. H
NMR (CDCl3): δ 3.10 (m, 2H), 3.63 (m, 2H), 4.63 (m, 4H), 4.98
(d, 2H, J 4.6), 5.77 (d, 2H, J 4.6), 6.29 (dd, 2H, J 8.0, 1.5), 6.44 (t,
2H, J 2.5), 6.65 (td, 2H, J 7.7, 1.5), 6.85 (dd, 2H, J 8.2, 1.7), 6.90
(td, 2H, J 8.0, 1.5), 7.31-7.38 (m, 6H), 7.42 (m, 4H). 13C NMR
(CDCl3): δ 38.9, 63.3, 68.4, 84.4, 113.8, 120.1, 121.1, 123.7,
128.1, 128.4, 128.7, 128.8, 133.7, 146.4, 149.2, 167.3. 15N NMR
(CDCl3): δ 138.6.
Compound 21a-Z. Formed in 12% with 21a-E (Condition B),
1H NMR (CDCl3): δ 3.16 (m, 2H), 3.50 (m, 2H), 4.73 (dd, 2H,
J 11.0, 4.3), 4.76 (dd, 2H, J 11.0, 4.3), 4.96 (d, 2H, J 4.8), 5.60 (d,
2H, J 4.8), 6.18 (t, 2H, J 4.3), 6.48 (dd, 2H, J 8.2, 1.6), 6.71 (td,
2H, J 7.8, 2.0), 6.90 (dd, 2H, J 8.0, 1.5), 6.92 (td, 2H, J 7.8, 2.0),
7.31-7.38 (m, 6H), 7.42 (m, 4H). 13C NMR (CDCl3): δ 38.8,
63.2, 64.4, 84.3, 114.8, 119.8, 121.5, 123.8, 128.3, 128.5, 128.8,
128.9, 134.3, 147.1, 149.2, 167.0.
Acknowledgment. The support of the University of Ku-
wait received through research grant no. SC02/07 and the
facilities of ANALAB and SAF (grants no. GS01/01, GS01/
03, GS03/01) are gratefully acknowledged.
Compound 16a-E. Yield 0.57 g (97%) (Condition A), 0.48 g
(83%) (Condition B), colorless oil, Rf = 0.41 (DCM/pet. ether/
EtOAc 1:1:1). MS: m/z = 588 (Mþ, 25%). HRMS = 588.2253
(C36H32N2O6 requires 588.2254). IR: 3061, 3029, 2926, 2852,
1764, 1751, 1597, 1496, 1453, 1410, 1257, 1213, 1114, 1040, 745,
Supporting Information Available: General experimental
methods and full experimental details for all reactions; char-
acterization data for all products; 1H NMR (600 MHz, CDCl3)
spectra of cis-anti-cis compound 6a (racemic) and cis-syn-cis
compound 11a (meso) (a) before addition of chiral shift reagent,
Eu(hfc)3 and (b) after addition of chiral shift reagent, Eu(hfc)3;
1H, 13C NMR and 15N full spectral assignment of 6a and
1
700. H NMR (CDCl3): δ 2.80 (d, 2H, J 11.2), 3.93 (d, 2H,
J 11.2), 4.56 (d, 2H, J 10.8), 4.61 (d, 2H, J 10.8), 5.07 (d, 2H,
J 4.5), 5.49 (dd, 2H, J 7.9, 1.6), 5.78 (d, 2H, J 4.5), 6.38 (t, 2H,
J 2.4), 6.48 (td, 2H, J 7.7, 1.4), 6.83 (dd, 2H, 8.1, 1.3), 6.93 (td,
2H, J 7.6, 1.6), 7.43 (m, 10H). 13C NMR (CDCl3): δ 37.4, 61.4,
67.6, 85.1, 112.4, 120.4, 122.9, 124.8, 127.4, 128.5, 128.7(2C),
134.2, 145.1, 150.4, 168.0. 15N NMR (CDCl3): δ 138.5.
11a and copies of H NMR and 13C NMR spectra and some
1
Compound 16a-Z. Formed in 17% as mixture with 4a-E
(Condition B), H NMR (CDCl3): δ 2.78 (d, 2H, J 10.8), 3.88
representative 2D NMR. This material is available free of
1
J. Org. Chem. Vol. 75, No. 13, 2010 4513